Developing innovative analytics to estimate age-and cause-specific child mortality for low- and middle-income countries
Developing innovative analytics to estimate age-and cause-specific child mortality for low- and middle-income countries
批准号:
9766323
负责人:
Li Liu
金额:
$19.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-17 至 2021-07-31
关键词:
5 year oldAgeAreaAutopsyBangladeshBayesian ModelingCategoriesCause of DeathCessation of lifeChildChild MortalityChildhoodChinaCommunitiesCountryCustomDataData QualityDatabasesDecision MakingDependenceDevelopmentDiseaseEffectivenessEpidemiologyEvaluationFoundationsFutureGenerationsGoalsGovernmentGroupingHeterogeneityImpact evaluationIncomeInternationalInterventionInvestmentsKnowledgeLifeLife Table ModelsLogicLongevityMeasurementMethodologyMethodsModelingNeonatal MortalityPatternPerformancePoliciesPolicy DevelopmentsPolicy MakingProgram EvaluationPublishingReproducibilityResearchResolutionResource AllocationSamplingSavingsSpecificitySustainable DevelopmentSystemUncertaintyUrsidae FamilyVariantWorkage groupbasehuman mortalityinnovationinsightlow and middle-income countrieslow income countrymortalitynovelpreventprogramsprototypescale uptheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Globally, an estimated 5.9 million children died before reaching their fifth birthday in 2015. The majority died in
low- and middle-income countries (LMICs), where quality information on age- and cause-specific child mortality
(ACSCM) is rarely available. Recently, the US government and the international community have renewed
their commitment to end preventable child deaths in a generation. We have been publishing modeled national
COD distributions for LMICs since 2010, where we estimated COD distribution for 0-1 and 1-59-month olds.
However, demographic and epidemiological evidence amounts to the conclusion that child COD is not uniform
in the 1-59-month period. National empirical data at levels of specificity below 1-59 months are often not
available in LMICs due to weak civil registration systems. Such data and estimates bear considerable scientific
value to inform the development and impact evaluation of age-specific childhood interventions and their
scale-up. Therefore, understanding the COD distribution among finer age groups in the 1-59-month period is
warranted. Previous research has suffered from four main drawbacks: (i) using custom-collected data to
understand age dynamics in a single cause; (ii) estimating ACSCM only in broad age groups; (iii) producing
estimates in each age group separately and independently; and (iv) developing ACSCM in two separate
estimation frameworks. The goals of this study are to systematically describe and make publicly available
empirical age patterns of child COD in LMICs with accurate uncertainty intervals, and to develop the innovative
theory-driven, parsimonious Bayesian hierarchical modeling framework to derive estimates of national COD
distributions in LMICs with partial data among finer age groups than previous research. We will achieve the
goals through three aims: 1) To extend and evaluate all-age demographic models to estimate age patterns in
child deaths with VR data. 2) To conceptualize, develop and evaluate novel simultaneous ACSCM estimators
using VR data in high-income countries; and 3) To extrapolate the unified ACSCM estimation framework to
LMICs. The proposed study has two important innovations. First, it proposes the first unified framework for
simultaneously estimating all-age, all-cause, age- and cause-specific child mortality. If successful, the study
will offer systematically estimated ACSCM with valid uncertainty for selected LMICs, and lay the foundation for
developing methods to systematically estimate ACSCM for all LMICs, including those low quality, limited, or
even no data. Second, this framework produces estimates at an age granularity not yet seen in published
research. This additional information is crucial to enable under-five child survival policy development and
program evaluation at granular levels of ages and causes that would further contribute to the Sustainable
Development Goals of equitably in reducing under-5 and neonatal mortality rates across countries. This study
will lay the groundwork for future research, such as extending the Human Mortality Database to children under
five to produce quality assessed, bias adjusted, and systematically organized ACSCM estimates.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1073/pnas.2001238117
发表时间:
2020-12-01
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Wang S, McCormick TH, Leek JT]
通讯作者:
Leek JT
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
-
批准号:10585388
-
项目类别:
-
资助金额:$57.83万
-
财政年份:2023
-
负责人:Li Liu
-
依托单位:
Interdisciplinary Systems-based Training for Precision Nutrition
-
批准号:10751913
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2023
-
负责人:Li Liu
-
依托单位:
Discover and Analyze Germline-Somatic Interactions in Cancer
-
批准号:10298814
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2021
-
负责人:Li Liu
-
依托单位:
Discover and Analyze Germline-Somatic Interactions in Cancer
-
批准号:10471353
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2021
-
负责人:Li Liu
-
依托单位:
Development Core
-
批准号:10226568
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2003
-
负责人:Li Liu
-
依托单位:
Development Core
-
批准号:10377560
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2003
-
负责人:Li Liu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: